BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026)

BridgeBio Pharma's (BBIO) quarterly Inventory Average came in at $29.9 million in Q1 2026, up 16.48% quarter-over-quarter from $25.6 million in Q4 2025.

BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026) Analysis & Trends

BridgeBio Pharma has disclosed Inventory Average across 2 years of filings, most recently posting $29.9 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.59 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 BridgeBio Pharma 12.90 Bn 11.97 Bn 184.58 Mn 29.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.87 Mn
Dec 31, 2025 25.64 Mn
Sep 30, 2025 21.40 Mn
Jun 30, 2025 11.12 Mn